U.S. federal trademark · Serial No. 78558827 · Reg. No. 3349448
[ Pharmaceutical drug development; pharmaceutical drug development and research services, namely, drug screening services; pharmaceutical development services for others, namely, evaluating the permeability and absorption of pharmaceuticals in the body and developing formulations to facilitate and improve the delivery of drugs into the body; pharmaceutical research and development services, namely, cell-based in vitro and in vivo screening services ]
[ Chemicals and excipients used in the manufacture of pharmaceuticals, namely, formulations which promote controlled release, reduced abuse potential, enhanced solubility, enhanced permeability or enhanced absorption of pharmaceutical agents ]
Pharmaceuticals preparations for the treatment of central nervous system disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.